Maximizing Outcomes in Respiratory Tract Infections in the Age of ResistanceNICOLAU, David P.Pharmacotherapy. 2002, Vol 22, Num 1, issn 0277-0008, 34 p., 2Conference Proceedings

Development of an HPLC method for the determination of doripenem in human and mouse serumSUTHERLAND, Christina; NICOLAU, David P.Journal of chromatography. B. 2007, Vol 853, Num 1-2, pp 123-126, issn 1570-0232, 4 p.Article

Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungsCRANDON, Jared L; KIM, Aryun; NICOLAU, David P et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 4, pp 837-839, issn 0305-7453, 3 p.Article

Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniaeNICOLAU, David P; AMBROSE, Paul G.The American journal of medicine. 2001, Vol 111, Num 9A, pp 13S-18S, issn 0002-9343Article

Tigecycline Displays In Vivo Bactericidal Activity against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae after 72-Hour Exposure PeriodTESSIER, Pamela R; NICOLAU, David P.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 640-642, issn 0066-4804, 3 p.Article

Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia modelKOOMANACHAI, Pornpan; KIM, Aryun; NICOLAU, David P et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 5, pp 982-987, issn 0305-7453, 6 p.Article

Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniaeDERYKE, C. Andrew; XIAOLI DU; NICOLAU, David P et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 3, pp 601-609, issn 0305-7453, 9 p.Article

Production and resolution of cantharidin-induced inflammatory blistersMAGLIO, Dana; NIGHTINGALE, Charles H; NICOLAU, David P et al.International journal of antimicrobial agents. 2003, Vol 22, Num 1, pp 77-80, issn 0924-8579, 4 p.Article

Optimizing economic outcomes in acute exacerbations of chronic bronchitisDESTACHE, Christopher J.Pharmacotherapy. 2002, Vol 22, Num 1, pp 12-17, issn 0277-0008, 2Conference Paper

The emerging role of atypical pathogens in community-acquired pneumoniaGLEASON, Patrick P.Pharmacotherapy. 2002, Vol 22, Num 1, pp 2-11, issn 0277-0008, 2Conference Paper

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase ProducersCRANDON, Jared L; NICOLAU, David P.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3299-3306, issn 0066-4804, 8 p.Article

In Vitro Evaluation of Novel Compounds against Selected Resistant Pseudomonas aeruginosa IsolatesHOUSMAN, Seth T; SUTHERLAND, Christina; NICOLAU, David P et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1646-1649, issn 0066-4804, 4 p.Article

Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosaHAGIHARA, Mao; KUTI, Joseph L; NICOLAU, David P et al.Diagnostic microbiology and infectious disease. 2012, Vol 72, Num 3, pp 258-262, issn 0732-8893, 5 p.Article

Validation of the Infectious Diseases Society of America/ American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniaeKONTOU, Paschalina; KUTI, Joseph L; NICOLAU, David P et al.The American journal of emergency medicine. 2009, Vol 27, Num 8, pp 968-974, issn 0735-6757, 7 p.Article

Probability of Pharmacodynamic Target Attainment With Standard and Prolonged-Infusion Antibiotic Regimens for Empiric Therapy in Adults With Hospital-Acquired PneumoniaKIM, Aryun; KUTI, Joseph L; NICOLAU, David P et al.Clinical therapeutics. 2009, Vol 31, Num 11, pp 2765-2778, issn 0149-2918, 14 p.Article

Pharmacodynamic Characterization of Ceftobiprole in Experimental Pneumonia Caused by Phenotypically Diverse Staphylococcus aureus StrainsLAOHAVALEESON, Somvadee; TESSIER, Pamela R; NICOLAU, David P et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2389-2394, issn 0066-4804, 6 p.Article

Pharmacokinetic and Pharmacodynamic Properties of MeropenemNICOLAU, David P.Clinical infectious diseases. 2008, Vol 47, issn 1058-4838, S32-S40, SUP1Article

Clinical Laboratory—Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized PatientsCRANDON, Jared L; MACVANE, Shawn H; NICOLAU, David P et al.Pharmacotherapy. 2014, Vol 34, Num 2, pp 203-209, issn 0277-0008, 7 p.Article

Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosaEAGYE, Kathryn J; KUTI, Joseph L; NICOLAU, David P et al.Infection control and hospital epidemiology. 2009, Vol 30, Num 8, pp 746-752, issn 0899-823X, 7 p.Article

Use of monte carlo simulation to assess the pharmacodynamics of β-lactams against Pseudomonas aeruginosa infections in children : A report from the OPTAMA programELLIS, Jennifer M; KUTI, Joseph L; NICOLAU, David P et al.Clinical therapeutics. 2005, Vol 27, Num 11, pp 1820-1830, issn 0149-2918, 11 p.Article

Pharmacokinetic and Pharmacodynamic Evaluation of P-873 versus Klebsiella pneumoniae in a Neutropenic Murine Thigh Infection ModelLAMB, Lucinda M; CRANDON, Jared L; NICOLAU, David P et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1971-1973, issn 0066-4804, 3 p.Article

Pharmacokinetics, pharmacodynamics and efficacy of novel Fabl inhibitor AFN-₁₂₅₂ against MSSA and MRSA in the murine thigh infection modelBANEVICIUS, Mary A; KAPLAN, Nachum; HAFKIN, Barry et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 26-31, issn 1120-009X, 6 p.Article

Development of an HPLC Method for the Determination of Anidulafungin in Human Plasma and SalineSUTHERLAND, Christina A; NICOLAU, David P; KUTI, Joseph L et al.Journal of chromatographic science. 2011, Vol 49, Num 5, pp 397-400, issn 0021-9665, 4 p.Article

In Vivo Efficacy of 1- and 2-Gram Human Simulated Prolonged Infusions of Doripenem against Pseudomonas aeruginosaCRANDON, Jared L; BULIK, Catharine C; NICOLAU, David P et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4352-4356, issn 0066-4804, 5 p.Article

Determination of BMS-284756, a new quinolone, in mouse serum by high-performance liquid chromatography with fluorescence detectionDAWEI XUAN; TURLEY, Christina; NIGHTINGALE, Charles H et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 765, Num 1, pp 37-43, issn 1387-2273Article